Brief: Lipocine Announces Filing Of New Drug Submission For TLANDO In Canada
09/06/2025 13:37
June 9 (Reuters) - Lipocine Inc LPCN.O: LIPOCINE ANNOUNCES FILING OF NEW DRUG SUBMISSION FOR TLANDO® IN CANADA Source text: ID:nPn6zM1DTa Further company coverage: LPCN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy